Follow the people · Insider
Ross Muken
Ross Muken files insider transactions with the SEC as a chief executive officer of SOPHiA GENETICS SA (SOPH). We hold 12 disclosed purchases and sales filed since 20 March 2026, 2 of them in the last 90 days.
- Files forSOPH
- Disclosed buys and sells12 in all, 2 in the last 90 days
- Last disclosure7 July 2026
Positions held
1 post we hold — a term names its own dates; a run of filings only says when they filed- Filed 19 March 2026 — 6 July 2026Chief Executive Officer · SOPHiA GENETICS SA (SOPH)17 Form 4 lines · source: SEC Form 4
Everything they disclosed
17 entries, newest first — one per disclosure report, one per Form 4 line- ▼ sold on the open market 9,838 shares of SOPHiA GENETICS SASEC Form 47 July 2026Ordinary Shares · traded 6 July 2026 · filed 7 July 2026
- ▼ sold on the open market 422 shares of SOPHiA GENETICS SASEC Form 423 June 2026Ordinary Shares · traded 22 June 2026 · filed 23 June 2026
- ▼ sold on the open market 761 shares of SOPHiA GENETICS SASEC Form 420 May 2026Ordinary Shares · traded 19 May 2026 · filed 20 May 2026
- ▼ sold on the open market 760 shares of SOPHiA GENETICS SASEC Form 421 April 2026Ordinary Shares · traded 20 April 2026 · filed 21 April 2026
- ▼ sold on the open market 2,800 shares of SOPHiA GENETICS SASEC Form 416 April 2026Ordinary Shares · traded 14 April 2026 · filed 16 April 2026
- ▼ sold on the open market 3,687 shares of SOPHiA GENETICS SASEC Form 414 April 2026Ordinary Shares · traded 10 April 2026 · filed 14 April 2026
- ▼ sold on the open market 4,442 shares of SOPHiA GENETICS SASEC Form 414 April 2026Ordinary Shares · traded 13 April 2026 · filed 14 April 2026
- ▼ sold on the open market 2,786 shares of SOPHiA GENETICS SASEC Form 410 April 2026Ordinary Shares · traded 8 April 2026 · filed 10 April 2026
- ▼ sold on the open market 1,950 shares of SOPHiA GENETICS SASEC Form 410 April 2026Ordinary Shares · traded 9 April 2026 · filed 10 April 2026
- was granted 431,211 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 2 April 2026 · filed 8 April 2026
- was granted 628,743 shares of SOPHiA GENETICS SA (a derivative holding)SEC Form 48 April 2026Share Option (Right to Buy) · traded 2 April 2026 · filed 8 April 2026
- ▼ sold on the open market 2,600 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 6 April 2026 · filed 8 April 2026
- ▼ sold on the open market 2,424 shares of SOPHiA GENETICS SASEC Form 48 April 2026Ordinary Shares · traded 7 April 2026 · filed 8 April 2026
- was granted 431,211 shares of SOPHiA GENETICS SASEC Form 43 April 2026Ordinary Shares · traded 2 April 2026 · filed 3 April 2026
- was granted 628,743 shares of SOPHiA GENETICS SA (a derivative holding)SEC Form 43 April 2026Share Option (Right to Buy) · traded 2 April 2026 · filed 3 April 2026
- ▼ sold on the open market 1,183 shares of SOPHiA GENETICS SASEC Form 420 March 2026Ordinary Shares · traded 19 March 2026 · filed 20 March 2026
- ▼ sold on the open market 1,183 shares of SOPHiA GENETICS SASEC Form 420 March 2026Ordinary Shares · traded 19 March 2026 · filed 20 March 2026
Positions come from the unitedstates/congress-legislators roster, the Office of Government Ethics and the SEC’s Form 4 index. Every disclosed line names its own source and links the document the government published; we print what the filing says and never a price we did not read from it. Headlines and links come from the GDELT Global Knowledge Graph — the story stays with the publisher. The portrait, where we have one, is the public-domain Congressional Bioguide photograph.